PGEN today
$4.72+$0.20 (+4.42%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourSymmetric Triangle
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $8.98
Key levels
Resistance$5.96
Resistance$5.11
Support$4.46
Support$3.51
Latest news & SEC filings
AnalystCitizens lifts Precigen price target after Q3 results
AnalystCitizens keeps Market Outperform on Precigen, lifts target to $12
SEC FilingPrecigen, Inc. filed a report on a major company event (Form 8-K)
All PGEN news →About Precigen
Precigen is a biopharmaceutical company that creates targeted treatments for cancer, immune system conditions, and illnesses caused by pathogens. Its first approved medicine, Papzimeos, is given to adults with recurrent respiratory papillomatosis, a rare disease linked to certain human papillomavirus types. The company also develops experimental therapies using its AdenoVerse and UltraCAR-T technology platforms. It conducts research and manufacturing in the United States, including a production site in Maryland.
Based on the company's 10-K filed Mar 25, 2026.
Nasdaq · Healthcare
PRECIGEN, INC. (PGEN)
What Is the Price Target for PGEN?
SEPT Low Target
$12.00
SEPT Mid Target
$13.00
SEPT High Target
$18.00
Analyst Consensus
$13.00
Is PGEN a Buy or Sell Right Now?
Thesis
- •Revenue growing 146.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PGEN.
Start Free Trial →Is PGEN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$9.24
41
Moat Score
NARROW
2/9
Piotroski Score
-15.7
Altman Z-Score
What Is Smart Money Doing with PGEN?
Insider Signal
SELLING
1 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Thomasian Harry Jr. | officer | Buy | 10,744 | $51K | Sep 23, 2026 |
| Thomasian Harry Jr. | officer | Buy | 42,918 | $100K | Sep 23, 2026 |
| Thomasian Harry Jr. | officer | Buy | 2 | $1.92 | Sep 23, 2026 |
| Thomasian Harry Jr. | officer | Buy | 1 | $1.21 | Sep 23, 2026 |
| KINDLER JEFFREY B | director | Sale | 185,000 | $1.4M | Aug 26, 2026 |
| AGEE NANCY H | director | Buy | 3,411 | $25K | Aug 21, 2026 |
| Thomasian Harry Jr. | officer | Sale | 41,884 | $183K | May 28, 2026 |
| Tennant Phil | officer | Sale | 30,272 | $132K | May 28, 2026 |
| Shah Rutul R | officer | Sale | 42,703 | $186K | May 28, 2026 |
| Lehr Donald P. | officer | Sale | 29,131 | $127K | May 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PGEN Growth Story
Revenue YoY
146.7%
3yr Revenue CAGR
-28.9%
EPS Growth YoY
-191.49%
FCF Growth YoY
-17.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for PGEN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PGEN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 12:00:12 | $4.72 | 5,957 | $$28K | BUY |
| 21:06:46 | $4.70 | 1,800 | $$8K | BUY |
| 21:00:31 | $4.72 | 24,077 | $$114K | BUY |
| 21:00:30 | $4.72 | 13,174 | $$62K | BUY |
| 21:00:30 | $4.72 | 7,200 | $$34K | BUY |
5 dark pool trades shown · $$246K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PGEN
PREVIEWSEPT Investing provides real-time options flow tracking for PGEN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Nov 20 | 9 | $$1500 | 100 | BLOCK |
| CALL | $7.5 | Jan 15 | 65 | $$2000 | 200 | BLOCK |
| CALL | $5 | Apr 16 | 156 | $$1170 | 13 | SWEEP |
| CALL | $5 | Apr 16 | 156 | $$1080 | 12 | SWEEP |
| CALL | $5 | Nov 20 | 9 | $$1500 | 100 | BLOCK |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PRECIGEN, INC. (PGEN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PGEN — frequently asked questions
What is PGEN stock price today?
PRECIGEN, INC. (PGEN) is at $4.72, up 4.42% (+$0.20) at the Nov 11, 2026 close.
Why is PGEN stock moving today?
Latest PGEN news — Nov 6, 2026: Citizens lifts Precigen price target after Q3 results · Nov 5, 2026: Citizens keeps Market Outperform on Precigen, lifts target to $12
What is the PGEN price target?
The average analyst price target for PGEN is $13.00, ranging from $12 to $18, based on 4 analysts. Latest: Citizens maintains on Nov 5, 2026.
What do analysts rate PGEN?
Analyst ratings for PGEN: 1 Buy, 8 Hold, 0 Sell — consensus Hold.
Did PGEN beat earnings?
PGEN last reported on Nov 4, 2026: EPS $0.08 vs $0.06 expected — a beat of 33.3%.
What is PGEN's P/E ratio?
PGEN trades at a P/E of 60.3 vs a Healthcare average of 17.7.
Does PGEN pay a dividend?
PGEN does not currently pay a dividend.
How much debt does PGEN have?
PRECIGEN, INC. reported $94M of debt and $15M of cash (Sep 30, 2026).
What are PGEN support and resistance levels?
Support: $4.46, $3.51. Resistance: $5.11, $5.96, $6.60.
What are insiders doing with PGEN?
Insider activity: SELLING, 1 buys and 6 sells in the last 90 days.
What is the latest news on PGEN?
Nov 6, 2026: Citizens lifts Precigen price target after Q3 results · Nov 5, 2026: Citizens keeps Market Outperform on Precigen, lifts target to $12 · Nov 4, 2026: Precigen, Inc. filed a report on a major company event (Form 8-K)